Testosterone Replacement in Renal Failure
Effect of Testosterone Replacement on Erythropoietin Stimulating Agent Use in End Stage Renal Disease Patients
Sponsor: Texas Tech University Health Sciences Center
Terminated
Study stopped for procedural difficulties and lack of personnel
Other terminated trials from Texas Tech University Health Sciences Center
- Back Pain · Sep 2019
- Vitamin D Deficiency · Phase PHASE2 · Jul 2019
- Breast Cancer · Phase NA · Dec 2018
- Healthy Volunteer · Jun 2018
- Low Back Pain · Phase PHASE4 · Jan 2018
See all terminations from Texas Tech University Health Sciences Center
Listed as NCT02712944, this PHASE1 trial focuses on Hypogonadism and remains terminated or withdrawn. Sponsored by Texas Tech University Health Sciences Center, it has been updated 9 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Jun 2019 — Jan 2021 [monthly]
Terminated PHASE1
Status: Recruiting → Terminated
-
Feb 2019 — Jun 2019 [monthly]
Recruiting PHASE1
▶ Show 4 earlier versions
-
Jan 2019 — Feb 2019 [monthly]
Recruiting PHASE1
-
Jun 2018 — Jan 2019 [monthly]
Recruiting PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Jul 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Texas Tech University Health Sciences Center
For direct contact, visit the study record on ClinicalTrials.gov .